All In Biotech

Drug Trial Radar · NCT07625215

A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation

A Placebo-controlled, Parallel-group, Double Blind, Randomized, Multi-cohort Phase 2 Study to Investigate Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BAY 3670549 in Adult Participants With Atrial Fibrillation.

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

360

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

May 16, 2030

Study completion May 16, 2030

Sponsor

Lead sponsor
BayerBayer (BAYRY)
Sponsor type
Industry
First posted
Jun 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main goal of this study is to find out how well BAY 3670549 works, how safe it is, how well people can tolerate it, and how the body handles the medicine. The study will compare BAY 3670549 to a placebo (a dummy treatment with no active medicine) in people with AF who need a treatment called electrical cardioversion. Electrical cardioversion is a procedure that helps the heart return to a normal rhythm. In this study, each participant will get a single intravenous (IV) infusion of either BAY 3670549 or a placebo. Participants will then be observed to see whether the heart rhythm returns to a normal rhythm. If it does not, electrical cardioversion can still be performed as planned. The study will look at how many participants return from AF to a normal rhythm, without needing electrical cardioversion and how long it takes. It will also show how many participants experience medical problems after treatment and how BAY 3670549 move into, through and out of the participants' body. The total duration of the study for an individual participant may be up two months. The findings from this study may contribute to the development of a new treatment option for people with AF.

Conditions

  • Atrial Fibrillation

Interventions

  • BAY 3670549Drug

    intravenous (IV) treatment

  • PlaceboOther

    intravenous (IV) treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with conversion from atrial fibrillation (AF) to sinus rhythm (SR), sustained for ≥1 minute, within 3 hours after start of study intervention administration, and prior to use of rescue therapy or other SoC for cardioversionTime frame: Up to 3 hours after start of administration of study intervention

Locations

30 sites in 8 countries. Site status is shown where the registry gives one.

  • UCSF Advanced Heart Failure Comprehensive Care Center

    San Francisco, California · Withdrawn

  • UCHealth University of Colorado Hospital - Cardiology

    Aurora, Colorado · Not yet recruiting

  • Massachusetts General Hospital - Cardiology

    Boston, Massachusetts · Not yet recruiting

  • Henry Ford Hospital - Cardiology

    Detroit, Michigan · Recruiting

  • M Health Fairview Heart Clinic - Maplewood

    Maplewood, Minnesota · Withdrawn

  • Duke University Hospital - Cardiology

    Durham, North Carolina · Not yet recruiting

  • Texas Health Heart and Vascular Specialists - Fort Worth

    Fort Worth, Texas · Not yet recruiting

  • CHRISTUS Trinity | Mother Frances Louis and Peaches Owen Heart Hospital - Electrophysiology Clinic

    Tyler, Texas · Not yet recruiting

  • UZ Leuven Gasthuisberg - Cardiology diseases department

    Leuven, Flemish Brabant, Belgium · Recruiting

  • Jessa Ziekenhuis | Hartcentrum Hasselt

    Hasselt, Limburg, Belgium · Not yet recruiting

  • AZ Delta | Clinical Trial Center - Cardiology

    Roeselare, West Flanders, Belgium · Not yet recruiting

  • University Multiprofile Hospital For Active Treatment Sveti Georgi' - EAD Department of Intensive Cardiology"

    Plovdiv, Plovdiv Province, Bulgaria · Not yet recruiting

  • Multiprofile Hospital for Active Treatment Knyaginya Klementina Sofia EAD | Cardiology Department

    Sofia, Sofia City Province, Bulgaria · Not yet recruiting

  • University Hospital for Active Treatment Tsaritsa Joanna - ISUL | Cardiology Clinic

    Sofia, Sofia City Province, Bulgaria · Recruiting

  • Multiprofile Hospital for Active Treatment Dr. Stefan Cherkezov | Base 1 - Cardiology Department

    Veliko Tarnovo, Veliko Tarnovo Province, Bulgaria · Recruiting

  • Medizinische Hochschule Hannover|Kardiologie und Angiologie

    Hanover, Lower Saxony, Germany · Not yet recruiting

  • Herz-und Diabeteszentrum NRW|Elektrophysiologie/Rhythmologie

    Bad Oeynhausen, North Rhine-Westphalia, Germany · Not yet recruiting

  • Klinikum Altenburger Land GmbH-Klinik für Kardiologie, Pneumologie und Internistische Intensivmedizin

    Altenburg, Thuringia, Germany · Recruiting

  • Semmelweis Egyetem, Varosmajori Sziv- és Ergyogyaszati Klinika

    Budapest, Hungary · Recruiting

  • Tolna Vármegyei Balassa János Kórház - I. Belgyógyászati Osztály: Kardiológia, Nefrológia

    Szekszárd, Tolna County, Hungary · Not yet recruiting

  • Ente Ecclesiastico Ospedale Generale Regionale Miulli - Cardiologia e UTIC

    Acquaviva delle Fonti, Apulia, Italy · Recruiting

  • Azienda Ospedaliero-Universitaria Policlinico Umberto I - Malattie Cardiovascolari

    Rome, Lazio, Italy · Not yet recruiting

  • Centro Cardiologico Monzino S.p.A. - UO Scompenso e Cardiologia Clinica

    Milan, Lombardy, Italy · Recruiting

  • Azienda Ospedaliero Universitaria Delle Marche - Clinica di Cardiologia e Aritmologia

    Torrette, The Marches, Italy · Not yet recruiting

  • Universitair Medisch Centrum Groningen

    Groningen, Netherlands · Not yet recruiting

  • Maastricht UMC

    Maastricht, Limburg, Netherlands · Not yet recruiting

  • American Heart of Poland S.A. - MCSN, PAKS w Chrzanowie - Oddział Intensywnej Opieki Kardiologicznej

    Chrzanów, Lesser Poland Voivodeship, Poland · Not yet recruiting

  • USK nr 4 w Lublinie - Kliniczny Odd. Kardiologii, Reh. Kardio., Ch. Wew. z Pododdzialem Intensywnej Opieki Kardio.

    Lublin, Lublin Voivodeship, Poland · Not yet recruiting

  • Samodzielny Publiczny Specjalistyczny Szpital Zachodni im. sw. Jana Pawla II

    Grodzisk Mazowiecki, Masovian Voivodeship, Poland · Recruiting

  • American Heart of Poland S.A. - PAKS Centrum Kardiologii i Kardiochirurgii w Bielsku-Białej - Oddział Kardiologii

    Bielsko-Biala, Silesian Voivodeship, Poland · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.